You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Chartwell Rx Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for CHARTWELL RX, and what generic and branded alternatives to CHARTWELL RX drugs are available?

CHARTWELL RX has three hundred and sixty-three approved drugs.

There is one tentative approval on CHARTWELL RX drugs.

Summary for Chartwell Rx
US Patents:0
Tradenames:255
Ingredients:242
NDAs:363

Drugs and US Patents for Chartwell Rx

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx LISINOPRIL lisinopril TABLET;ORAL 075994-003 Jul 1, 2002 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx ROPINIROLE HYDROCHLORIDE ropinirole hydrochloride TABLET;ORAL 079050-007 May 29, 2008 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 073289-001 Mar 25, 1994 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx TADALAFIL tadalafil TABLET;ORAL 210716-002 Dec 29, 2020 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx METHYLDOPA AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; methyldopa TABLET;ORAL 070544-001 Jan 15, 1986 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx PREGABALIN pregabalin CAPSULE;ORAL 212865-001 Mar 20, 2020 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx METHYLDOPA methyldopa TABLET;ORAL 018934-001 Jun 29, 1984 RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Chartwell Rx

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chartwell Rx LIMBITROL amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 016949-001 Approved Prior to Jan 1, 1982 4,316,897 ⤷  Try a Trial
Chartwell Rx MOBAN molindone hydrochloride TABLET;ORAL 017111-006 Approved Prior to Jan 1, 1982 3,491,093 ⤷  Try a Trial
Chartwell Rx MOBAN molindone hydrochloride TABLET;ORAL 017111-007 Approved Prior to Jan 1, 1982 3,491,093 ⤷  Try a Trial
Chartwell Rx MOBAN molindone hydrochloride TABLET;ORAL 017111-008 Approved Prior to Jan 1, 1982 3,491,093 ⤷  Try a Trial
Chartwell Rx MOBAN molindone hydrochloride TABLET;ORAL 017111-005 Approved Prior to Jan 1, 1982 3,491,093 ⤷  Try a Trial
Chartwell Rx LIMBITROL DS amitriptyline hydrochloride; chlordiazepoxide TABLET;ORAL 016949-002 Approved Prior to Jan 1, 1982 4,316,897 ⤷  Try a Trial
Chartwell Rx MOBAN molindone hydrochloride TABLET;ORAL 017111-004 Approved Prior to Jan 1, 1982 3,491,093 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.